ABUS
ABUS

Arbutus Biopharma Corp

NASDAQ · Biotechnology
$3.84
+0.17 (+4.63%)
Analyst Consensus
Strong Buy
9 analysts
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,234.6% upside
Low Target $34.47
Average Target $51.25
High Target $59.24
Current Price $3.84
Current
$3.84
Target
$51.25
$34.47 $51.25 avg $59.24